Navigation Links
UMMC and Mayo Clinic sign agreement to increase research and training
Date:7/9/2010

JACKSON, Miss. The University of Mississippi Medical Center will partner with the renowned Mayo Clinic on a series of initiatives intended to convert laboratory discoveries into new therapies and train a new generation of medical scientists.

An agreement between the institutions, titled the Translational Research and Training Program for Clinician Scientists, was formally announced July 8 at UMMC during a visit from Mayo Clinic researchers. The agreement sets the stage for a wide array of possible collaborations in the future.

Through training, mentorship and research collaborations, the two institutions will look for ways to translate the understanding of diseases from basic-science research into clinically applicable methods, drugs, devices and therapies that will benefit patients.

"This agreement represents the completion of a couple years of effort toward extending current collaborations and the advent of new opportunities between our institutions," said Dr. John E. Hall, UMMC associate vice chancellor for research.

"UMMC has certain expertise and accomplishments and Mayo, as one of the most respected names in academic medicine, also has expertise and accomplishments in areas that are complementary to UMMC. The goal is to make a two-way street for training, research and learning opportunities."

The collaboration lays the groundwork for more specific collaborations, research and training agreements in the future.

For instance, Mayo and UMMC might exchange junior faculty members, post-doctoral fellows and residents so each can learn from the host institution's expertise. Collaborative research agreements could deepen the knowledge about a given disease, provide access to equipment and resources for clinician scientists and lead to development of drugs, therapies and medical devices that improve care for patients.

"Our combined expertise will enable us to work together to discover and implement new and better ways to improve the health of people and communities," said Dr. Robert Rizza, Mayo Clinic executive dean of research. "We look forward to collaborating with UMMC."

As a recipient of one of 46 national Clinical and Translational Science Awards (CTSA), the Mayo Clinic has a strong translational research program. UMMC has significant basic-science expertise and unique epidemiological research programs especially in hypertension, cardiovascular disease and renal disease. But it is still working to develop its clinical research infrastructure.

"UMMC has the opportunity to develop leading clinical and population-research programs. We are strong in some areas of basic science research and need more translational and clinical investigations," Hall said. The CTSAs are administered by the National Institutes of Health's National Center for Research Resources.

Researchers at the Mayo Clinic will gain access to the Mississippi patient population, which has some of the nation's highest rates of heart disease, obesity, diabetes, stoke and hypertension.

As well, Mississippi has an African-American population particularly affected by those diseases that otherwise would not be easily accessible for Mayo researchers, Hall said.

The importance of biomedical research to understand and reverse health disparities, particularly in African-American populations, can't be overstated. UMMC and two historically black institutions, Jackson State University and Tougaloo College, are a decade into the Jackson Heart Study. The study investigates cardiovascular disease among 5,300 African-Americans in Mississippi's Capital. It's the nation's largest longitudinal study of cardiovascular disease risk factors in African-Americans.

UMMC is also a principal site for the 20-year-running Atherosclerosis Risk in Communities Study, a larger population study, in which about a quarter of the 16,000 participants are African-Americans from the Jackson metro area.

Under the agreement, detailed arrangements could be more easily formed that give researchers at Mayo increased access to data and participants of the studies.

The agreement also formalizes ongoing research relationships between the two institutions. Investigators from Mayo and UMMC for several years have worked together on numerous projects. Those include research into hypertension-induced renal injury, the genetics of kidney disease, the genetics of microangiopathic brain injury as well as in research consultation, lectures, and symposia.

"This relationship sets up a wide platform for both institutions to work together," Hall said. "As more faculty members, fellows and residents find out about it, we'll see more projects, training and collaboration efforts."


'/>"/>

Contact: Jack Mazurak
jmazurak@umc.edu
601-984-1970
University of Mississippi Medical Center
Source:Eurekalert

Related biology news :

1. A new journal where molecular biology meets clinical research
2. Self-assembling nano-fiber gel delivers high concentrations of clinically approved drugs
3. Biochemistry of human physiology in health and disease is focus of updated clinical text
4. New book helps medical students master clinical skills
5. Mayo Clinic research on tamoxifen leads to recommendation for CYP2D6 gene test
6. In just 5 years, gene discovery to clinical trial of potential treatment
7. TGen, Scottsdale Healthcare, Mayo Clinic study new drug to stimulate immune system of cancer victims
8. Mayo Clinic: Brain disorder suggests common mechanism may underlie many neurodegenerative diseases
9. Far-reaching genetics topics to be addressed: 2009 Annual Clinical Genetics Meeting, March 25-29
10. Genome Medicine: Bridging the gap between research and clinical practice
11. 3 new informatics pilot projects to aid clinical and translational scientists nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... 30, 2016 Not many of us realize that we spend ? of ... we need to do it well. Inadequate sleep levels have been found to lead ... diabetes, and even cancer. Maybe now is the best time to rethink ... them to manage their sleep quality? Continue Reading ... ...
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's ... Systems) ... largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of an ...
(Date:11/22/2016)... 22, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... and Life Sciences Awards as "Most Outstanding in ... unprecedented year of recognition and growth for MedNet, which ... years. iMedNet ™ , MedNet,s ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016  The Multiple Myeloma ... from the MMRF CoMMpass Study SM —the largest and ... precision medicine in multiple myeloma—will be presented at the ... Meeting & Exposition in San Diego ... to optimize treatment strategies, as well as identify pathways ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... share findings demonstrating the value of DNA microarray comparative genomic hybridization (array ... San Antonio Breast Cancer Symposium. Using molecular test results from tumors with ...
(Date:12/2/2016)... ... 2016 , ... Orthogonal, a Chicago-based medical device software company, ... 510(k) clearance for their flagship medical device, SimplECG. , With this FDA approval, ... rely on cloth-based nanosensors. While other companies have attempted to focus on wearable ...
(Date:12/2/2016)... Laboratories, a world leader in rapid infectious disease tests, introduced the Company,s newest product, ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , , bioLytical was invited by ... the INSTI HIV Self Test to 350 pharmacy representatives in Nairobi ...
Breaking Biology Technology: